Zutripro

Catarrh, Migraine, Coughing + 55 more

Treatment

6 FDA approvals

20 Active Studies for Zutripro

What is Zutripro

Chlorpheniramine

The Generic name of this drug

Treatment Summary

Diphenhydramine is a medication used to treat allergies, hay fever, nasal stuffiness, hives, and asthma. It works by blocking a substance in the body called histamine, which is responsible for allergic reactions. This drug is commonly used and is less likely to cause drowsiness and sedation than other antihistamines. It is also used in veterinary medicine.

Rynatuss

is the brand name

Zutripro Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Rynatuss

Chlorpheniramine

1960

47

Approved as Treatment by the FDA

Chlorpheniramine, also known as Rynatuss, is approved by the FDA for 6 uses including Acute Bronchitis and Cold .

Acute Bronchitis

Used to treat Cough in combination with Hydrocodone

Cold

Used to treat Cold in combination with Hydrocodone

Allergic Rhinitis (AR)

Allergy to Tree Pollen

upper respiratory symptoms

Used to treat upper respiratory symptoms in combination with Hydrocodone

Hypersensitivity

Used to treat Allergic Reaction in combination with Hydrocodone

Effectiveness

How Zutripro Affects Patients

Allergic reactions occur when an allergen causes an antibody to stick to the surface of mast cells and basophils. This interaction triggers a chain reaction that leads to the release of a chemical known as histamine. Histamine then attaches itself to H1 receptors in the body, which can cause symptoms like itching, enlarged blood vessels, headaches, and difficulty breathing. Chlorpheniramine is a drug that works by blocking histamine from attaching to H1 receptors. This provides temporary relief from sneezing, itchy eyes, runny nose, and other common allergic reactions.

How Zutripro works in the body

Chlorpheniramine works by blocking the action of histamine in the body. Histamine causes negative symptoms like itches and sneezes, and chlorpheniramine helps to reduce these effects.

When to interrupt dosage

The prescribed measure of Zutripro is contingent upon the acknowledged ailment, including upper respiratory symptoms, Coughing and Inflammation. The magnitude of dosage depends on the technique of delivery (e.g. Kit; Syrup - Oral or Liquid - Oral) outlined in the table beneath.

Condition

Dosage

Administration

Sinusitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Seasonal Allergic Conjunctivitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Lacrimal Apparatus Diseases

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Coughing

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Migraine

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Pink Eye

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Productive cough

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Rhinorrhea

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

House Dust Mite Allergy

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Inflammation

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

IgA Vasculitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Nose

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Acute Bronchitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Asthma

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

upper respiratory symptoms

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Conjunctivitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Upper respiratory tract congestion

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Cold

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Asthma

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Dermatitis, Allergic Contact

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Warnings

There are 20 known major drug interactions with Zutripro.

Common Zutripro Drug Interactions

Drug Name

Risk Level

Description

Amoxapine

Major

The metabolism of Amoxapine can be decreased when combined with Chlorpheniramine.

Anagrelide

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Anagrelide.

Arsenic trioxide

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Arsenic trioxide.

Artemether

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Artemether.

Asenapine

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Asenapine.

Zutripro Toxicity & Overdose Risk

The highest dose of the drug that has been found to be toxic to rats, mice, and guinea pigs is 306mg/kg, 130mg/kg, and 198mg/kg respectively. The drug may also be slightly toxic to women of childbearing age.

image of a doctor in a lab doing drug, clinical research

Zutripro Novel Uses: Which Conditions Have a Clinical Trial Featuring Zutripro?

163 active trials are investigating the potential of Zutripro to provide relief for Allergy to vaccine, Ocular Irritation and Coughing.

Condition

Clinical Trials

Trial Phases

Migraine

47 Actively Recruiting

Phase 4, Not Applicable, Phase 1, Phase 3, Phase 2, Early Phase 1

Asthma

85 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Transfusion Reaction

0 Actively Recruiting

Pink Eye

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Hypersensitivity

1 Actively Recruiting

Phase 4

Headache

0 Actively Recruiting

ocular hyperemia

0 Actively Recruiting

Influenza

0 Actively Recruiting

Conjunctivitis

0 Actively Recruiting

Coughing

0 Actively Recruiting

Airway secretion clearance therapy

0 Actively Recruiting

Nose

0 Actively Recruiting

Allergy to vaccine

0 Actively Recruiting

Angioedema

0 Actively Recruiting

Rhinorrhea

0 Actively Recruiting

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Cold

0 Actively Recruiting

Lacrimal Apparatus Diseases

0 Actively Recruiting

Coughing

0 Actively Recruiting

Zutripro Reviews: What are patients saying about Zutripro?

5

Patient Review

1/20/2013

Zutripro for Cold Symptoms

I had a nasty sinus infection that led to lung problems. I was constantly coughing and felt awful. This medication worked very quickly for me - almost immediately after taking the first dose, my cough stopped. Just be warned that it can make you drowsy.

5

Patient Review

11/14/2012

Zutripro for Cold Symptoms

I took this medicine last night and it was very effective. I didn't cough for 7 hours, which is the longest I've gone without coughing in a long time. The only downside is the cost, but it's worth it to me.

5

Patient Review

5/10/2012

Zutripro for Cough

This medicine worked great for me - my cough was gone almost as soon as I took it. It made me feel very relaxed and sleepy, but that was a welcome side effect given how badly I had been coughing. I would definitely recommend this to anyone else with a similar problem.

5

Patient Review

10/17/2012

Zutripro for Cough

I have bronchitis and this medication helped with my cough, though not as much as tussionex pennkinetic.

5

Patient Review

5/3/2012

Zutripro for Cough

This medication was really effective in treating my flu symptoms. It cleared up my coughing, runny nose, and congestion quickly.

5

Patient Review

5/13/2013

Zutripro for Cough

This treatment provides a much-needed energy boost when you're feeling run down from a cold. I never felt jittery or "cotton-headed," and there were no withdrawal symptoms either. I would definitely recommend it to others!

5

Patient Review

2/6/2014

Zutripro for Cough

This is the only cough medication I've found that almost instantly stops my coughing, whether it's dry or productive.

5

Patient Review

12/3/2012

Zutripro for Cough

This cost me $100. It has not completely stopped my cough, however, it has kept me from sleeping. I have now been awake for 27 hours. My throat feels very dry and sore.

5

Patient Review

1/28/2013

Zutripro for Cold Symptoms

This medication was very effective for me. It quickly stopped my cough and running nose and allowed me to sleep soundly through the night.

4.7

Patient Review

1/27/2014

Zutripro for Cold Symptoms

I was prescribed this for bronchitis, but it gives me migraines and keeps me awake. I'm not sure why you would prescribe this drug to someone with bronchitis.

4

Patient Review

9/9/2012

Zutripro for Cough

This medication was a life-saver. I had been coughing for weeks on end due to bronchitis and pneumonia, and this was the first time in forever that I was able to get a full night's sleep. Within minutes of taking it, my cough subsided and I started feeling better. And the best part? The effects lasted for over 12 hours!

2.7

Patient Review

11/21/2012

Zutripro for Cough

The medication did what it was supposed to do; however, I found the side effects (nosebleeds) to be really unpleasant.

2.7

Patient Review

12/1/2012

Zutripro for Cold Symptoms

I was very surprised by how expensive this treatment was.

2.3

Patient Review

2/23/2012

Zutripro for Cough

1.7

Patient Review

2/4/2014

Zutripro for Cough

I didn't find this treatment very effective. It certainly didn't help me sleep, which was disappointing because that's one of the main reasons I wanted to try it.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about zutripro

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What does pseudoephedrine do?

"Pseudoephedrine is a decongestant that works to relieve a stuffed or blocked nose by reducing the swelling of blood vessels in the sinus cavities."

Answered by AI

What is Zutripro used for?

"Zutripro can be used to relieve symptoms such as a runny or blocked nose, sneezing, itchy eyes, coughing and congestion in the sinuses, which are caused by conditions such as allergies, colds or flu."

Answered by AI

Clinical Trials for Zutripro

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

VR-Enhanced PMR for Post-Burn Symptoms

18+
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Recruiting
Has No Placebo

Johns Hopkins Bayview Medical Center

Sheera Lerman Zohar, PhD

Have you considered Zutripro clinical trials?

We made a collection of clinical trials featuring Zutripro, we think they might fit your search criteria.
Go to Trials
Image of Arizona State University in Phoenix, United States.

App-based Breathing Program for Migraine

18+
All Sexes
Phoenix, AZ

Migraine is one of the most common neurological disorders, characterized by recurrent headaches, sensitivity to light and movement, nausea, and autonomic dysregulation. Although mind-body interventions like biofeedback have shown their efficacy, they remain underutilized due to barriers such as transportation, time constraints, lack of awareness, stigma, and cost. A targeted approach to enhancing HRV is HRV biofeedback (HRVB), a technique using visual or auditory feedback to help people regulate HRV through slow-paced breathing and positive emotional regulation to promote ANS balance and emotional resilience. Investigators will conduct a remotely delivered pilot RCT of an 8-week, 10 min/day, novel app-based HRVB intervention compared to a sham control intervention (matching intervention time and attention with no biofeedback component) in adult with chronic migraine. Investigators hypothesize data collected from the study will: a) support the feasibility and acceptability of the remotely delivered app-based HRVB intervention among adults with chronic migraine, and b) provide insights into refining the intervention by examining patterns of change in migraine and psychological outcomes from pre- to post-intervention.

Waitlist Available
Online Trial

Arizona State University

Have you considered Zutripro clinical trials?

We made a collection of clinical trials featuring Zutripro, we think they might fit your search criteria.
Go to Trials
Image of Johns Hopkins Medicine in Baltimore, United States.

Embolization for Migraine

18 - 80
All Sexes
Baltimore, MD

This study is to test the safety and feasibility of a procedure called embolization of the middle meningeal arteries (MMA), using a product called Onyx. Embolization creates a plug in the arteries. MMA embolization with Onyx is not approved for use in patients with migraines, but is currently used in patients with subdural hematomas. The FDA is allowing the use of Onyx in this study. It is thought that by using Onyx to block the middle meningeal arteries, the amount of migraine-causing substances which are released into the brain's bloodstream will be reduced. The company that manufactures Onyx, Medtronic, is providing the supplies for this study. Participants will be in the study for about 8 months after enrolling, including 6 months of follow up after the procedure. The participants will be asked to complete a daily headache diary and continue the participant's regular migraine medications. Participants will also have several clinic visits and be asked to provide blood samples for research.

Waitlist Available
Has No Placebo

Johns Hopkins Medicine

Risheng Xu, MD, PhD

Medtronic

Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD

Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.

Phase 2
Waitlist Available

National Institutes of Health Clinical Center (+1 Sites)

Luca T Giurgea, M.D.

Have you considered Zutripro clinical trials?

We made a collection of clinical trials featuring Zutripro, we think they might fit your search criteria.
Go to Trials